Congratulations to this stellar team - such an important and timely study Amin Nassar, MD Elias Bou Farhat

1/ #RCC histological subtypes display diverse epigenetic configurations. Allelic imbalances play a role in modifying TF binding sites, especially through candidate SNPs.

Potential targets for future investigations and therapeutic strategies?

Amin Nassar, MD Sarah Abou Alaiwi…

The CarDS Lab is growing. We're recruiting for many roles:

(1) Clinical postdoctoral fellow
(2) Computational postdoctoral fellow
(3) Data Scientist
(4) Program Coordinator

Find out more here:
🔗cards-lab.org/join-the-team

Please share with your network!
Yale School of Medicine @Yale

Thanks to colleagues around the globe for your support of the ASCO elections!

Ready to get to work to deliver on ASCO goals relating to access, knowledge and the profession!

Let us do this together !

—Toni

JUST IN: U.S. FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell carcinoma (RCC) following PD1 and VEGF inhibitors!

A great day for the field and a new option for our Kidney Cancer patients!!!!

Via ASCO #FDAAlerts OncoAlert

Study presented at ESMO - Eur. Oncology #ESMO3 by…

Great to have Dr. Anju Nohria from Brigham and Women's Hospital at Yale Cardiology Grand Rounds for an amazing talk on CardioOncology.

You can watch here: youtube.com/live/XQNU8077-…

1/ Exciting talk about the landscape of HCM by Carolyn Ho @ #HeartofCardio #BacktoCardio23

▪️Genetic testing is + in 30 % of pts in HCM and + > 60% of pts w/ HCM w/ positive Fam Hx

▪️Variants in sarcomere genes are most frequency associated w/ HCM (MYH 7 and MYBPC 3)

Re: Germline Variants Associated with Toxicity to Immune Checkpoint Bl... sciencedirect.com/science/articl…

A glorious day for Cardiology!

Harlan Krumholz will take on the helm as the next EIC JACC Journals!

Anyone who knows Harlan knows it’s going to be transformative for cardiology & scientific publishing

It’s been an honor to have had him as a mentor & friend over the years! Can’t wait!

Welcome to the new Yale Cardiology fellows!!!

Exciting work presented by Ziwei Zhang on cistrome-wide association studies of kidney cancer at #ASHG2023 ! The rapidly growing number of epigenomic profiles from cancer are a gold-mine for studying #GWAS risk variants in noncoding DNA.

This is my patient and his story is heartbreaking. Thank you Circulation Quality and Outcomes for amplifying his voice. We can do better for him.

*Posted with patient’s permission (and at his request) ahajournals.org/doi/10.1161/CI…

Pan-cancer epigenomic study: an innovative approach through 1 cc plasma/liquid biopsies! @sylvanbaca Dana-Farber #FreedmanLab OncoAlert

#ESMO23 ESMO - Eur. Oncology with concomitant paper in Nature Medicine

nature.com/articles/s4159…

Thank you to VJ Oncology for highlighting our work in the Stage III unresectable EGFR-positive setting! More to come soon
vjoncology.com/video/m0q-snwl…

Great to see Nature Rev Immunol highlighting our work in Cancer Cell on the immune implications of MTAP deletions!

nature.com/articles/s4157…

cell.com/cancer-cell/fu…

So proud of this superstar!! Amin Nassar, MD

Excited to share our collaboration with Dr. Gavin Oudit where we noted that 44% of heart transplant patients have damaging genetic variants in cardiomyopathy genes. Important that we consider genetic testing in patients with non-ischemic cardiomyopathy! #HeartFailure #genetic

Check out our review led by Brigham and Women's Medicine Residents superstar⭐️#@WIM
Alex Spacht on unique features of HF in women, out in this month's special CVD in Women issue of Climacteric.
👉:tandfonline.com/eprint/PQVB8VS…